"Not only is our Board of Directors accomplished and highly qualified in providing strategic guidance as we build a pipeline of women's health therapeutics, the diversity of membership seen on our Board is reflective of the real world," said
"Diversity is of crucial importance to our corporate culture, and evidence supports that having a balanced and diverse Board is associated with increased innovation, competitiveness and sustainable growth, not to mention a more prosperous and inclusive workplace."
In addition to honoring members of the GK15, the event included a panel discussion and a fireside chat on gender and racially diverse corporate boards.
About Juniper Pharmaceuticals
Juniper Pharmaceuticals™ is a trademark of
Crinone® is a registered trademark of
Forward Looking Statements
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to Juniper's ability to leverage the 505(b)(2) pathway for its product candidates and the expectation that Juniper's core operating business will enable targeted product development investments. Management believes that these forward-looking statements are reasonable as and when made. However, such forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause actual results to differ materially from those projected in the forward-looking statements. For a discussion of certain risks and uncertainties associated with Juniper Pharmaceuticals' forward-looking statements, please review the Company's reports filed with the
Director, Corporate Communications,
917-673-5775 / email@example.com
212-600-1902 / firstname.lastname@example.org
212-600-1902 / email@example.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/juniper-pharmaceuticals-recognized-for-board-diversity-at-get-konnected-9th-anniversary-event-300430931.html